Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

ABT-089 candidate drug for Alzheimer's disease

April 12, 1996

Neruocrine Biosciences, Ciba-Geigy ally for MS research

April 12, 1996

Carbonic anhydrase inhibitor tested for parkinsonism

April 12, 1996

Genentech to develop neurturin for neurodegenerative disorders

April 12, 1996

Genetic markers for manic depression discovered

April 12, 1996

Atypical antipsychotics from Spanish university

April 12, 1996

Generic fluoxetine available in Canada

April 5, 1996

Genentech files for new indication for alteplase

April 5, 1996

Zeneca selects NMDA antagonist for preclinical study

April 5, 1996

SIBIA , Ciba-Geigy collaborate to develop CNS drugs

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 1, 2025.
Novo Nordisk licenses Lexicon’s preclinical obesity drug in $1B deal
BioWorld Science
As companies continually search for next-generation obesity prospects, one of the leaders in the disease space, Novo Nordisk A/S, has obtained an exclusive...
Corcept looks to NDA following strong phase III ovarian cancer data
BioWorld
Relacorilant, a cortisol modulator from Corcept Therapeutics Inc., produced new and strong phase III results in treating platinum-resistant ovarian cancer. The...
Otsuka submits first BLA to FDA for sibeprenlimab in IgAN
BioWorld
Otsuka Pharmaceutical Development & Commercialization Inc. filed its BLA with the U.S. FDA for sibeprenlimab to treat immunoglobulin A nephropathy (IgAN). The...